000			01921 a2200517 4500
005			20250517003948.0
264		0	_c20150414
008			201504s 0 0 eng d
022			_a1549-4713
024	7		_a10.1016/j.ophtha.2014.09.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aTse, Brian C
245	0	0	_aEnophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma. _h[electronic resource]
260			_bOphthalmology _cFeb 2015
300			_a435-7 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aAtrophy
650	0	4	_aChemotherapy, Cancer, Regional Perfusion _xadverse effects
650	0	4	_aChoroid _xpathology
650	0	4	_aChoroid Diseases _xchemically induced
650	0	4	_aCombined Modality Therapy
650	0	4	_aDiseases in Twins
650	0	4	_aEnophthalmos _xchemically induced
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aLaser Coagulation
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aOphthalmic Artery
650	0	4	_aRetinal Neoplasms _xdrug therapy
650	0	4	_aRetinoblastoma _xdrug therapy
650	0	4	_aScleritis _xchemically induced
650	0	4	_aTopoisomerase I Inhibitors _xadministration & dosage
650	0	4	_aTopotecan _xadministration & dosage
650	0	4	_aTwins, Monozygotic
700	1		_aKaste, Sue C
700	1		_aBrennan, Rachel
700	1		_aOrr, Brent
700	1		_aWilson, Matthew W
773	0		_tOphthalmology _gvol. 122 _gno. 2 _gp. 435-7
856	4	0	_uhttps://doi.org/10.1016/j.ophtha.2014.09.021 _zAvailable from publisher's website
999			_c24394570 _d24394570